Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23082
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BIELEN, Rob | - |
dc.contributor.author | Verrando, R. | - |
dc.contributor.author | PENDERS, Joris | - |
dc.contributor.author | Oris, E. | - |
dc.contributor.author | Nevens, F. | - |
dc.contributor.author | ROBAEYS, Geert | - |
dc.date.accessioned | 2017-02-08T08:05:57Z | - |
dc.date.available | 2017-02-08T08:05:57Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD), Boston - Massachusetts, 11-15/11/2016 | - |
dc.identifier.uri | http://hdl.handle.net/1942/23082 | - |
dc.description.abstract | Hepatitis C viral infection (HCV) has become a curable disease due to the development of direct acting antivirals (DAA). Therefore, the World Health Organization (WHO) has set a target to eliminate HCV. The largest group at risk for HCV at present are people who inject drugs (PWID), especially in the western world. Due to various barriers, this risk group is still underserved for HCV. Our goal was to study if a case management policy of a known PWID cohort could improve uptake for screening and treatment. | - |
dc.description.sponsorship | This trial was supported by Gilead Sciences. No direct or indirect benefits were granted to Gilead Sciences BVBA. | - |
dc.language.iso | en | - |
dc.rights | American Association for the study of liver diseases (AASLD) | - |
dc.title | Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject Drugs | - |
dc.type | Conference Material | - |
local.bibliographicCitation.conferencedate | 2016, November 11-15 | - |
local.bibliographicCitation.conferencename | The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD) | - |
local.bibliographicCitation.conferenceplace | Boston - Massachusetts | - |
local.bibliographicCitation.jcat | C2 | - |
local.type.refereed | Non-Refereed | - |
local.type.specified | Conference Poster | - |
item.fullcitation | BIELEN, Rob; Verrando, R.; PENDERS, Joris; Oris, E.; Nevens, F. & ROBAEYS, Geert (2016) Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject Drugs. In: The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD), Boston - Massachusetts, 11-15/11/2016. | - |
item.accessRights | Closed Access | - |
item.fulltext | With Fulltext | - |
item.contributor | BIELEN, Rob | - |
item.contributor | Verrando, R. | - |
item.contributor | PENDERS, Joris | - |
item.contributor | Oris, E. | - |
item.contributor | Nevens, F. | - |
item.contributor | ROBAEYS, Geert | - |
Appears in Collections: | Research publications |
Page view(s)
18
checked on Jun 22, 2022
Download(s)
4
checked on Jun 22, 2022
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.